« Previous
Next »
Lung Cancer
Volume 70, Issue 2
, Pages
205-210
, November 2010
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)
To access this article, please choose from the options below
PII: S0169-5002(10)00070-X
doi: 10.1016/j.lungcan.2010.02.005
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Lung Cancer
Volume 70, Issue 2
, Pages
205-210
, November 2010
